Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kateřina Smešný Trtková"'
Autor:
Petra Luzna, Denisa Weiser Drozdkova, Pavla Flodrova, Katarina Ondruskova, Ivo Uberall, Jiri Minarik, Zdenek Kolar, Katerina Smesny Trtkova
Publikováno v:
Biomedical Papers, Vol 167, Iss 1, Pp 43-49 (2023)
Aims. The aim of this study was to compare the expression profile of selected DNA methyltransferases and global DNA methylation status in patients with different phases of multiple myeloma (MM) . For the analysis, different cellular populations inclu
Externí odkaz:
https://doaj.org/article/da9369f7aa9d4fa88aba3942419199aa
Autor:
Pavel Hurník, Zuzana Chyra, Tereza Ševčíková, Jan Štembírek, Kateřina Smešný Trtková, Daria A. Gaykalova, Marcela Buchtová, Eva Hrubá
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Carcinomas of the oral cavity and oropharynx belong among the ten most common malignancies in the human population. The prognosis of head and neck squamous cell carcinoma (HNSCC) is determined by the degree of invasiveness of the primary tumor and by
Externí odkaz:
https://doaj.org/article/7c08e8d0d1a54f2892d0a45881e22b4e
Autor:
Lukáš Masaryk, Denisa Weiser Drozdková, Karolina Słoczyńska, Ján Moncol’, David Milde, Radka Křikavová, Justyna Popiół, Elżbieta Pękala, Katarína Ondrušková, Ivan Nemec, Kateřina Smešný Trtková, Pavel Štarha
Publikováno v:
Inorganic Chemistry Frontiers. 10:3307-3318
Highly anti-myeloma effective, DNA non-binding diiodidoplatinum(ii) complexes markedly exceeded the potency of cisplatin and carry potential for single-agent therapy of a hard-to-treat type of cancer (multiple myeloma).
Publikováno v:
Current Oncology, Vol 28, Iss 3, Pp 2087-2096 (2021)
Multiple myeloma (MM) is a malignant disease of the plasma cells representing approximately 10% of all hemato-oncological diseases. Detection of the disease is most probable at around 65 years of age, and the average survival of patients is estimated
Externí odkaz:
https://doaj.org/article/b3f16697d8d94578ae4e66994d7f6b68